Skip to main content
Erschienen in: Diabetologia 2/2004

01.02.2004 | Rapid Communication

Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes

verfasst von: T. Bäcklund, E. Palojoki, A. Saraste, A. Eriksson, P. Finckenberg, V. Kytö, P. Lakkisto, E. Mervaala, L.-M. Voipio-Pulkki, M. Laine, I. Tikkanen

Erschienen in: Diabetologia | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Diabetes is known to reduce survival after myocardial infarction. Our aim was to examine whether diabetes is associated with enhanced cardiomyocyte apoptosis and thus interferes with the post-infarction remodelling process in myocardium in rat.

Methods

Four weeks after intravenous streptozotocin (diabetic groups) or citrate buffer (controls) injection, myocardial infarction was produced by ligation of left descending coronary artery. Level of cardiomyocyte apoptosis was quantified by TUNEL and caspase-3 methods. Collagen volume fraction and connective tissue growth factor were determined under microscope. Left ventricular dimensions were evaluated by echocardiography and planimetry.

Results

The number of apoptotic cardiomyocytes was equally high in diabetic and non-diabetic rats after 1 week from infarction. At 12 weeks after infarction the number of apoptotic cells was higher in the diabetic as compared to non-diabetic rats both in the border zone of infarction and in non-infarcted area. Correspondingly, left ventricular end diastolic diameter, relative cardiac weight, connective tissue growth factor-expression and fibrosis were increased in diabetic compared with non-diabetic rats with myocardial infarction.

Conclusion/interpretation

Sustained cardiomyocyte apoptosis, left ventricular enlargement, increased cardiac fibrosis and enhanced profibrogenic connective tissue growth factor expression were detected after myocardial infarction in experimental diabetes. Apoptotic myocyte loss could be an important mechanism contributing to progressive dilatation of the heart and poor prognosis after myocardial infarction in diabetes.
Literatur
1.
Zurück zum Zitat Mukamal KJ, Nesto RW, Cohen MC, et al. (2001) Impact of diabetes on long-term survival after acute myocardial infarction: Comparability of risk with prior myocardial infarction. Diabetes Care 24:1422–1427 Mukamal KJ, Nesto RW, Cohen MC, et al. (2001) Impact of diabetes on long-term survival after acute myocardial infarction: Comparability of risk with prior myocardial infarction. Diabetes Care 24:1422–1427
2.
Zurück zum Zitat Paulson DJ (1997) The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res 34:104–112PubMed Paulson DJ (1997) The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res 34:104–112PubMed
3.
Zurück zum Zitat Palojoki E, Saraste A, Eriksson A, et al. (2001) Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol 280:H2726–H2731 Palojoki E, Saraste A, Eriksson A, et al. (2001) Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol 280:H2726–H2731
4.
Zurück zum Zitat Cheng W, Kajstura J, Nitahara JA, et al. (1996) Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226:316–327CrossRefPubMed Cheng W, Kajstura J, Nitahara JA, et al. (1996) Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226:316–327CrossRefPubMed
5.
Zurück zum Zitat Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ (2002) Hyperglycemia-induced apoptosis in mouse myocardium. Mitochondrial cytochrome c-mediated caspase-3 activation pathway. Diabetes 51:1938–1948 Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ (2002) Hyperglycemia-induced apoptosis in mouse myocardium. Mitochondrial cytochrome c-mediated caspase-3 activation pathway. Diabetes 51:1938–1948
6.
Zurück zum Zitat Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki L-M (1997) Apoptosis in human acute myocardial infarction. Circulation 95:320–323PubMed Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki L-M (1997) Apoptosis in human acute myocardial infarction. Circulation 95:320–323PubMed
7.
Zurück zum Zitat Saraste A, Pulkki K (2000) Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45:528–537PubMed Saraste A, Pulkki K (2000) Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45:528–537PubMed
8.
Zurück zum Zitat Thomas WP, Gaber CE, Jacobs GJ (1993) Recommendations for standard in transthoracic two-dimensional echocardiography in the dog and cat. J Vet Intern Med 7:247–252PubMed Thomas WP, Gaber CE, Jacobs GJ (1993) Recommendations for standard in transthoracic two-dimensional echocardiography in the dog and cat. J Vet Intern Med 7:247–252PubMed
9.
Zurück zum Zitat Brooks WW, Bing OHL, Robinson KG, Slawsky MT, Chaletsky DM, Conrad CH (1997) Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from spontaneous hypertensive rat. Circulation 96:4002–4010PubMed Brooks WW, Bing OHL, Robinson KG, Slawsky MT, Chaletsky DM, Conrad CH (1997) Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from spontaneous hypertensive rat. Circulation 96:4002–4010PubMed
10.
Zurück zum Zitat Finckenberg P, Inkinen K, Ahonen J, et al. (2003) Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol 163:355–366PubMed Finckenberg P, Inkinen K, Ahonen J, et al. (2003) Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol 163:355–366PubMed
11.
Zurück zum Zitat Bäcklund T, Palojoki E, Saraste A, et al. (2003) Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction. Cardiovasc Res 57:727–737CrossRefPubMed Bäcklund T, Palojoki E, Saraste A, et al. (2003) Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction. Cardiovasc Res 57:727–737CrossRefPubMed
12.
Zurück zum Zitat Saraste A, Pulkki K, Kallajoki M, et al. (1999) Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 29:380–386CrossRefPubMed Saraste A, Pulkki K, Kallajoki M, et al. (1999) Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 29:380–386CrossRefPubMed
13.
Zurück zum Zitat Sam F, Sawyer DB, Chang DL-F, et al. (2000) Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol 279:H422–H428 Sam F, Sawyer DB, Chang DL-F, et al. (2000) Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol 279:H422–H428
14.
Zurück zum Zitat Fiordaliso F, Li B, Latini R, et al. (2000) Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Lab Invest 80:513–527PubMed Fiordaliso F, Li B, Latini R, et al. (2000) Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Lab Invest 80:513–527PubMed
15.
Zurück zum Zitat Fiordaliso F, Leri A, Cesselli D, et al. (2001) Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50:2363–2375 Fiordaliso F, Leri A, Cesselli D, et al. (2001) Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 50:2363–2375
16.
Zurück zum Zitat Miric G, Dallemagne C, Endre Z, Margolin S, Taylor SM, Brown L (2001) Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol 133:687–694PubMed Miric G, Dallemagne C, Endre Z, Margolin S, Taylor SM, Brown L (2001) Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol 133:687–694PubMed
17.
Zurück zum Zitat Riva E, Andreoni G, Bianchi R, et al. (1998) Changes in diastolic function and collagen content in normotensive and hypertensive rats with long-term streptozotocin-induced diabetes. Pharmacol Res 37:233–240CrossRefPubMed Riva E, Andreoni G, Bianchi R, et al. (1998) Changes in diastolic function and collagen content in normotensive and hypertensive rats with long-term streptozotocin-induced diabetes. Pharmacol Res 37:233–240CrossRefPubMed
18.
Zurück zum Zitat Marfella R, D’Amico M, Di Filippo C, et al. (2002) Myocardial infarction in diabetic rats: role of hyperglycemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 45:1172–1181 Marfella R, D’Amico M, Di Filippo C, et al. (2002) Myocardial infarction in diabetic rats: role of hyperglycemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 45:1172–1181
19.
Zurück zum Zitat Shiomi T, Tsutsui H, Ikeuchi M, et al. (2003) Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol 42:165–172CrossRefPubMed Shiomi T, Tsutsui H, Ikeuchi M, et al. (2003) Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol 42:165–172CrossRefPubMed
20.
Zurück zum Zitat Duncan MR, Frazier KS, Abramson S, et al. (1999) Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: downregulation by cAMP. FASEB J 13:1774–17PubMed Duncan MR, Frazier KS, Abramson S, et al. (1999) Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: downregulation by cAMP. FASEB J 13:1774–17PubMed
21.
Zurück zum Zitat Way KJ, Isshiki K, Suzuma K, et al. (2002) Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C [beta]2 activation and diabetes. Diabetes 51:2709–2718 Way KJ, Isshiki K, Suzuma K, et al. (2002) Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C [beta]2 activation and diabetes. Diabetes 51:2709–2718
22.
Zurück zum Zitat Hishikawa K, Oemar BS, Nakaki T (2001) Static pressure regulates connective tissue growth factor expression in human mesangial cells. J Biol Chem 276:16797–16816CrossRefPubMed Hishikawa K, Oemar BS, Nakaki T (2001) Static pressure regulates connective tissue growth factor expression in human mesangial cells. J Biol Chem 276:16797–16816CrossRefPubMed
Metadaten
Titel
Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes
verfasst von
T. Bäcklund
E. Palojoki
A. Saraste
A. Eriksson
P. Finckenberg
V. Kytö
P. Lakkisto
E. Mervaala
L.-M. Voipio-Pulkki
M. Laine
I. Tikkanen
Publikationsdatum
01.02.2004
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 2/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1311-5

Weitere Artikel der Ausgabe 2/2004

Diabetologia 2/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.